Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCHR1 | Q99705 | 6/20 | 0.42 |
| ▸ | F9 | P00740 | 1/20 | 0.40 |
| ▸ | HDAC8 | Q9BY41 | 4/20 | 0.38 |
| ▸ | HDAC6 | Q9UBN7 | 4/20 | 0.38 |
| ▸ | MAOA | P21397 | 1/20 | 0.37 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.36 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.35 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.35 |
| ▸ | DEGS1 | O15121 | 1/20 | 0.35 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.35 |
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.34 |
| ▸ | F10 | P00742 | 1/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
| ▸ | EPAS1 | Q99814 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1749247 | 0.96 | MCHR1 (0.44) | MCHR1F9HDAC8HDAC6MAOA | |
| SCHEMBL1749595 | 0.84 | MCHR1 (0.50) | MCHR1HDAC8HDAC6MAOAHDAC3 | |
| SCHEMBL1749476 | 0.83 | MCHR1 (0.46) | MCHR1F9HDAC8HDAC6MAOA | |
| SCHEMBL1749536 | 0.82 | MCHR1 (0.45) | MCHR1F9HDAC8HDAC6MAOA | |
| SCHEMBL1750076 | 0.82 | MCHR1 (0.43) | MCHR1F9HDAC8HDAC6MAOA | |
| SCHEMBL1750282 | 0.82 | MCHR1 (0.43) | MCHR1F9HDAC8HDAC6MAOA | |
| SCHEMBL1749583 | 0.81 | MCHR1 (0.44) | MCHR1F9HDAC8HDAC6MAOA | |
| SCHEMBL1749270 | 0.81 | MCHR1 (0.42) | MCHR1F9HDAC8HDAC6MAOA | |
| SCHEMBL1750792 | 0.81 | MCHR1 (0.44) | MCHR1F9HDAC8HDAC6MAOA | |
| SCHEMBL1749537 | 0.79 | MCHR1 (0.45) | MCHR1F9HDAC8HDAC6MAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1597228-A2 | SUBSTITUTED N-ARYLHETEROCYCLES, METHOD FOR PRODUCTION AND USE THEREOF AS MEDICAMENTS | Sanofi-Aventis Deutschland GmbH (DE) | 2005-11-23 | — | — | EP | disclosed |
| WO-2004072025-A2 | SUBSTITUTED N-ARYLHETEROCYCLES, METHOD FOR PRODUCTION AND USE THEREOF AS MEDICAMENTS | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2004-08-26 | — | — | WO | disclosed |